Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.
Source | Last Updated |
---|---|
Alliance of Genome Resources | October 9, 2024 |
Disease ID | Disease Name | Alliance of Genome Resources ID | Species | Gene ID | Gene Symbol ▲ | FlyGlycoDB | Evidence Code Names | References |
---|---|---|---|---|---|---|---|---|
DOID:10907 | microcephaly | Xenbase:XB-GENE-951402 | Xenopus tropicalis (tropical clawed frog) | 780091 | mfsd2a |
|
||
DOID:10907 | microcephaly | ZFIN:ZDB-GENE-041114-166 | Danio rerio (zebrafish) | 492810 | mfsd2aa |
|
||
DOID:0070277 | primary autosomal recessive microcephaly 15 | ZFIN:ZDB-GENE-041114-166 | Danio rerio (zebrafish) | 492810 | mfsd2aa |
|
||
DOID:0070277 | primary autosomal recessive microcephaly 15 | ZFIN:ZDB-GENE-040801-89 | Danio rerio (zebrafish) | 445176 | mfsd2ab |
|
||
DOID:0110722 | neuronal ceroid lipofuscinosis 7 | ZFIN:ZDB-GENE-060818-29 | Danio rerio (zebrafish) | 564342 | mfsd8 |
|
||
DOID:0110722 | neuronal ceroid lipofuscinosis 7 | Xenbase:XB-GENE-998879 | Xenopus laevis (African clawed frog) | 444062 | mfsd8.L |
|
||
DOID:0070253 | congenital disorder of glycosylation type IIa | ZFIN:ZDB-GENE-070410-54 | Danio rerio (zebrafish) | 100000478 | mgat2 |
|
||
DOID:0070253 | congenital disorder of glycosylation type IIa | Xenbase:XB-GENE-978789 | Xenopus tropicalis (tropical clawed frog) | 448439 | mgat2 |
|
||
DOID:0070253 | congenital disorder of glycosylation type IIa | Xenbase:XB-GENE-978795 | Xenopus laevis (African clawed frog) | 414590 | mgat2.L |
|
||
DOID:0070253 | congenital disorder of glycosylation type IIa | Xenbase:XB-GENE-17345473 | Xenopus laevis (African clawed frog) | 444674 | mgat2.S |
|
||
DOID:0070253 | congenital disorder of glycosylation type IIa | Xenbase:XB-GENE-22169454 | Xenopus tropicalis (tropical clawed frog) | 100493854 | mgat2l |
|
||
DOID:1793 | pancreatic cancer | Xenbase:XB-GENE-968212 | Xenopus tropicalis (tropical clawed frog) | 100124983 | mgat4a |
|
||
DOID:1793 | pancreatic cancer | ZFIN:ZDB-GENE-070912-27 | Danio rerio (zebrafish) | 563038 | mgat4a |
|
||
DOID:1793 | pancreatic cancer | Xenbase:XB-GENE-6078255 | Xenopus laevis (African clawed frog) | 443870 | mgat4a.L |
|
||
DOID:1793 | pancreatic cancer | Xenbase:XB-GENE-17342666 | Xenopus laevis (African clawed frog) | 108709721 | mgat4a.S |
|
||
DOID:576 | proteinuria | Xenbase:XB-GENE-995554 | Xenopus tropicalis (tropical clawed frog) | 100145551 | mgat5 |
|
||
DOID:576 | proteinuria | ZFIN:ZDB-GENE-060616-238 | Danio rerio (zebrafish) | 724006 | mgat5 |
|
||
DOID:0080855 | Parkinsonism | WB:WBGene00003232 | Caenorhabditis elegans | 191707 | mgl-1 |
|
||
DOID:12849 | autistic disorder | WB:WBGene00003232 | Caenorhabditis elegans | 191707 | mgl-1 |
|
||
DOID:2377 | multiple sclerosis | WB:WBGene00003232 | Caenorhabditis elegans | 191707 | mgl-1 |
|
||
DOID:1826 | epilepsy | WB:WBGene00003232 | Caenorhabditis elegans | 191707 | mgl-1 |
|
||
DOID:5419 | schizophrenia | WB:WBGene00003232 | Caenorhabditis elegans | 191707 | mgl-1 |
|
||
DOID:1094 | attention deficit hyperactivity disorder | WB:WBGene00003232 | Caenorhabditis elegans | 191707 | mgl-1 |
|
||
DOID:0050741 | alcohol dependence | WB:WBGene00003232 | Caenorhabditis elegans | 191707 | mgl-1 |
|
||
DOID:11832 | visual epilepsy | WB:WBGene00003232 | Caenorhabditis elegans | 191707 | mgl-1 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024